Wisconsin state employee GLP-1 coverage in 2027: $200 copay
By John Samaras, price analyst · Prices checked Nov 16, 2026
From January 1, 2027, the Wisconsin Group Health Insurance Program covers anti-obesity GLP-1s for non-Medicare members, in a new pharmacy tier with a $200 copay. In 2026 these drugs are not covered.
What it costs without insurance
If your plan says no
Eden$99 a monthIncludes medication, provider review and shippingCheck price →
Collective$59 a month, drug priceLowest price on our chartCheck price →
Who this affects
Non-Medicare members of the Group Health Insurance Program that the Department of Employee Trust Funds (ETF) runs for state and local employers. Medicare members do not get this coverage in 2027.
When it starts
The Group Insurance Board approved it on March 13, 2026. It takes effect on January 1, 2027.
If you lose coverage: cash now
Two cash programs to check.
No insurance needed.
Prices checked Nov 16, 2026.
- Eden$99 a monthIncludes medication, provider review and shippingcompounded semaglutidecompounded tirzepatide $129 a monthCheck price →Eden's GLP-1 page, then an online assessment
- Check price →
- Compounded semaglutide and tirzepatide prices, from $59 a month
- Find your GLP-1 program in four questions
What the ETF notice says
Members will have a $200 copay for these weight-loss drugs.
- ETF says there will be no prior authorization or eligibility requirements. Members need a prescription.
- In the high-deductible plan, members pay the full pharmacy cost until the combined deductible is met, and then the $200 copay applies.
- ETF says some FDA-approved anti-obesity drugs will be covered. The Navitus formulary will show which ones.
- Copays for GLP-1s used for type 2 diabetes do not change.
- ETF's Medicare Part D benefit still does not cover anti-obesity drugs in 2027, and ETF points Medicare members to the Medicare GLP-1 Bridge.
Sources:
- Wisconsin ETF, GIB Approves Cost Sharing, GLP-1s for Weight Loss for 2027, dated March 16, 2026, read November 15, 2026.
- Wisconsin ETF, 2027 Non-Medicare Benefit and Plan Design Changes, dated no date printed, read November 15, 2026.
What to do before January 1
- After January 1, check the Navitus formulary or call Navitus to see which drugs sit in the new tier.
- On the high-deductible plan, compare the cash price with what you would pay before your deductible is met.
- Medicare members can check the Medicare GLP-1 Bridge.
The Medicare GLP-1 Bridge in 2027. Employers changing GLP-1 coverage in 2027.
What cash costs today
Compounded semaglutide and tirzepatide are pharmacy-made versions that are not Wegovy, Ozempic, Zepbound or Mounjaro.
Compounded prices are the monthly drug price at the lowest-priced program. Any membership is listed on that program's own page.
| Cash route | Monthly price | Checked |
|---|---|---|
| Compounded semaglutide | From $59 | November 16, 2026 |
| Compounded tirzepatide | From $69 | November 16, 2026 |
| Wegovy pill from NovoCare | From $149 at the 1.5mg starter dose | November 16, 2026 |
| Zepbound vial from LillyDirect | From $299 at 2.5mg | November 16, 2026 |
Buying cash in late November? GLP-1 Black Friday and Cyber Monday offers shows each program's 30-day low and high.
Frequently asked questions
Do Wisconsin state employees need prior authorization for GLP-1 weight-loss drugs in 2027?
Is the $200 copay open to Medicare members?
How does the $200 copay work on the high-deductible plan?
Cash does not go through your plan and does not count toward its deductible. Federal plan GLP-1 changes for 2027. GLP-1 coverage by payer.